Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0022104 (
irritable bowel syndrome
)
8,033
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Contrarily to a widely prevalent opinion, celiac disease frequently affects adults, and only rarely reveals itself by the classical triad of diarrhea--weight loss--nutritional deficiency. In addition to isolated deficiencies, most frequently
iron
and calcium-vitamin D, celiac disease is commonly associated with atypical, sometimes very commonplace manifestations, such as abdominal symptoms reminiscent of those of
irritable bowel syndrome
, or type I diabetes. The diagnostic process is now made easier by the availability of antitransglutaminase antibodies dosage, a simple, trustworthy, sensitive and specific test. This review article discusses the many clinical pictures which should prompt the clinician to rule out celiac disease, and provides practical guidelines as to the use and interpretation of serologic tests.
...
PMID:[Celiac disease in disguise]. 1621 1
Chronic muscle pain (myalgia) is a common problem throughout the world. Seemingly simple, it is actually a difficult problem for the clinician interested in determining the aetiology of the pain, as well as in managing the pain. The two common muscle pain conditions are fibromyalgia and myofascial pain syndrome. Fibromyalgia is a chronic, widespread muscle tenderness syndrome, associated with central sensitisation. It is often accompanied by chronic sleep disturbance and fatigue, visceral pain syndromes like
irritable bowel syndrome
and interstitial cystitis. Myofascial pain syndrome is an overuse or muscle stress syndrome characterised by the presence of trigger points in muscle. The problem these syndromes pose lies not in making the diagnosis of muscle pain. Rather, it is the need to identify the underlying cause(s) of persistent or chronic muscle pain in order to develop a specific treatment plan. Chronic myalgia may not improve until the underlying precipitating or perpetuating factor(s) are themselves managed. Precipitating or perpetuating causes of chronic myalgia include structural or mechanical causes like scoliosis, localised joint hypomobility, or generalised or local joint laxity; and metabolic factors like depleted tissue
iron
stores, hypothyroidism or Vitamin D deficiency. Sometimes, correction of an underlying cause of myalgia is all that is needed to resolve the condition.
...
PMID:A review of myofascial pain and fibromyalgia--factors that promote their persistence. 1625 10
The present report describes a young woman with no previous gastrointestinal complaints who was initially diagnosed with postinfective
irritable bowel syndrome
(
IBS
) after a confirmed case of Campylobacter jejuni enteritis. However, because of persistent diarrhea, new-onset bloating and the development of
iron
and vitamin deficiencies, serological markers for celiac disease (CD) were evaluated. A positive tissue transglutaminase immunoglobulin A antibody test and repeat endoscopy with duodenal biopsy showing a Marsh IIIa lesion confirmed the diagnosis of CD. Infectious gastroenteritis is a well-established risk factor for the development of
IBS
, and there is recent evidence that it could play a role in the initiation and exacerbation of inflammatory bowel disease. The present case suggests that the clinical expression of CD can be unmasked by an acute gastrointestinal infection and supports the hypothesis that environmental factors other than gliadin may play a role in the clinical onset of CD in a genetically susceptible host. The increasing availability of serological testing and upper endoscopy has led to increasingly frequent diagnoses of CD and recognition that it may mimic
IBS
. The present case findings suggest that CD should be considered in the differential diagnosis of persistent
IBS
-like symptoms after an episode of infectious gastroenteritis.
...
PMID:Clinical onset of celiac disease after an episode of Campylobacter jejuni enteritis. 1763 49
The distribution of genes encoding different
iron
acquisition systems in enteroaggregative Escherichia coli (EAEC) from adults with
irritable bowel syndrome
and from healthy controls was examined using a PCR assay. As many as 95.5% of EAEC carried the chuA gene coding for a haem receptor, and the majority of these strains also had yersiniobactin-encoding genes. Apart from yersiniobactin, enterobactin was the siderophore most frequently associated with EAEC among those strains examined. Genes encoding aerobactin and salmochelin siderophores were less frequent in the group of EAEC.
...
PMID:Distribution of genes encoding iron uptake systems among enteroaggregative Escherichia coli strains isolated from adults with irritable bowel syndrome. 1904 Apr 81
Anaemia is the most frequent extraenteric complication of inflammatory bowel disease (
IBD
, Crohn's disease and ulcerative colitis). A disabling complication of
IBD
, anaemia worsens the patient's general condition and quality of life, and increases hospitalization rates. The main types of anemia in
IBD
are iron deficiency anemia and anemia of chronic disease. The combination of the serum transferrin receptor with ferritin concentrations and inflammatory markers allows a reliable assessment of the
iron
status. Iron deficiency is usually treated with oral
iron
supplements. However, it is less effective in
IBD
and may lead to an increased inflammatory activity through the generation of reactive oxygen species. A systematic review of anemia in
IBD
, its pathogenetic features, epidemiology, diagnosis and therapy based on the evidence from recent studies will be the focus of this article.
...
PMID:[Pathophysiological-based diagnosis and therapy of iron-deficient anaemia in inflammatory bowel disease]. 1919 27
Environmental factors substantially contribute to the development of chronic intestinal inflammation in the genetically susceptible host. Nutritional components like
iron
may act as pro-oxidative mediators affecting inflammatory processes and cell stress mechanisms. To better characterize effects of dietary
iron
on epithelial cell responses under the pathological conditions of chronic intestinal inflammation, we characterized the protein expression profile (proteome) in primary intestinal epithelial cells (IEC) from
iron
-adequate and low-
iron
fed wild-type (WT) and TNFDeltaARE/WT mice. We performed all possible comparisons between the 4 groups according to genotype or diet. Histological analysis of
iron
-adequate fed TNFDeltaARE/WT mice (approximately 0.54 mg of
iron
/day) revealed severe ileal inflammation with a histopathology score of 8.3+/-0.91 (score range from 0-12). Interestingly, low-
iron
fed mice (approximately 0.03 mg of
iron
/day) were almost completely protected from the development of inflammatory tissue destruction (histopathology score of 2.30+/-0.73). In total, we identified 74 target proteins with significantly altered steady state expression levels in primary IEC using 2D-gel electrophoresis (2D SDS-PAGE) and peptide mass fingerprinting via MALDI-TOF mass spectrometry (MS). Interestingly, the overlap between the comparison of
iron
-adequate fed WT and TNFDeltaARE/WT mice (inflamed conditions) and the comparison between the
iron
-adequate and
iron
-low fed TNFDeltaARE/WT mice (absence of inflammation) revealed 4 contrarily regulated proteins including aconitase 2, catalase, intelectin 1 and fumarylacetoacetate hydrolase (FAH). These proteins are associated with energy homeostasis, host defense, oxidative and endoplasmic reticulum (ER) stress responses. In conclusion, the
iron
-low diet affected the epithelial cell proteome and inhibited the development of chronic intestinal inflammation, suggesting a critical role for nutritional factors in the pathogenesis of
IBD
.
...
PMID:Intestinal epithelial cell proteome from wild-type and TNFDeltaARE/WT mice: effect of iron on the development of chronic ileitis. 1942 69
Anemia is the most prevalent extraintestinal complication of
IBD
. It can affect quality of life and ability to work, and can also increase the hospitalization rate in patients with
IBD
. Although the causes of anemia in
IBD
are multifactorial, iron deficiency anemia (IDA) is the most common. Assessment of the
iron
status of patients who have a condition associated with inflammation, such as
IBD
, by using common biochemical values is insufficient. However, new indices of
iron
metabolism (for instance ferritin:transferrin receptor ratio, reticulocyte hemoglobin content or percentage of hypochromic red blood cells) may help to improve the assessment of
iron
status in patients with
IBD
. The treatment of IDA traditionally involves oral
iron
supplementation. However, because of extensive gastrointestinal adverse effects, and data showing that the use of oral
iron
in
IBD
may be associated with disease exacerbation, current guidelines suggest that
iron
supplementation in
IBD
should be administered intravenously. This Review provides an overview of
iron
homeostasis in health before discussing diagnostic and therapeutic strategies for IDA in patients with
IBD
.
...
PMID:Diagnosis and management of iron deficiency anemia in patients with IBD. 2092 67
Anemia in
IBD
is the result of a combination of iron deficiency and anemia of chronic disease. Therapy of
IBD
is relief of inflammation, but the drugs usage may cause the development hemolytic anemia and myelodysplastic syndrome. We studied the effect of basic therapy on the incidence of anemia and assess the impact of modern biological therapies on the main markers of AHZ. A total of 153 patients with ulcerative colitis (UC) and 53 patients with Crohn's disease (CD), which at the time of the study received basic anti-inflammatory therapy for at least 1 year. All patients underwent blood tests,
iron
metabolism parameters were determined by the level of erythropoietin and G-gepsidina C reactive protein. Modern biological therapy increases the effectiveness of the treatment of anemia in patients with
IBD
. The use of Remicade gives a quick positive response, which is due to the decrease of gepsidin negative influence on
iron
metabolism and unlocking the synthesis of erythropoietin. The use of MSCs does not inhibit the synthesis of erythropoietin, and is likely to stimulate erythropoiesis at the erythroblast precursors.
...
PMID:[Risk of development of clinical and pathogenetic features of anemia on the background of basic therapy of inflammatory bowel disease]. 2262 93
More than one-third of patients with
IBD
are affected by extraintestinal manifestations or extraintestinal complications beyond the intestinal manifestation of the disease. The most common manifestations include arthropathies, mucocutaneous and ophthalmological manifestations, as well as conditions affecting the hepatobiliary system, both in Crohn's disease and ulcerative colitis. However, less frequent manifestations, such as pulmonary or neurological manifestations, should also be considered in patients with
IBD
. Several extraintestinal manifestations follow the course of the underlying intestinal activity, whereas others are independent from the intestinal inflammation. Extraintestinal complications such as
iron
-deficiency anaemia and osteoporosis are consequences of the intestinal disease or of disease-specific treatment. As extraintestinal manifestations and complications strongly influence quality of life, and to avoid severe complications, adequate treatment is mandatory in affected patients. We provide a comprehensive overview of different extraintestinal manifestations and complications, including their management, in patients with
IBD
.
...
PMID:Extraintestinal manifestations and complications in IBD. 2383 89
Severe fatigue is a common complaint among patients. This report presents a clinical case of a woman complaining of fatigue associated with diarrhea and myalgia that were first attributed to emotional stress and depression. Initially, the patient was diagnosed with chronic fatigue and
irritable bowel syndrome
. The patient followed nutritional and physical exercise programs without any improvement. Other clinical conditions, such as nutritional deficiencies, endocrine dysfunctions, autoimmune diseases and neoplasias, were then assessed. During clinical investigation, serum ferritin and
iron
levels were abnormally elevated despite normal hemoglobin levels, which pointed to an iron overload syndrome later diagnosed as hemochromatosis. It is possible that the symptoms were triggered by the amenorrhea caused by the levonorgestrel-releasing intrauterine system used for contraception.
...
PMID:Levonorgestrel-releasing intrauterine system and iron overload syndrome. 2384 14
<< Previous
1
2
3
Next >>